CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 21 enrolled
Drug / intervention
Cranial Electrical Stimulation Fisher-Wallace Stimulator (Model FW100)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02163967
NCT02163967Phase 4Completed
CompareCT.gov

Effect of Cranial Electrical Stimulation (CES) on Autonomic Regulation

Weill Medical College of Cornell University·interventional·Posted Jun 16, 2014·Updated Oct 11, 2019

In Brief

A Phase 4 clinical trial evaluating Cranial Electrical Stimulation Fisher-Wallace Stimulator (Model FW100) for Autonomic Nervous System Imbalance. Completed, enrolled 21 participants across 1 site.

Detailed Summary

The hypothesis is that CES stimulation will dose dependently increase parasympathetic tone. Healthy subjects will have three 20 minute sessions of CES stimulation, at three different intensities of stimulation, with each session occurring on a separate day. Effect on parasympathetic tone will determined by measuring high frequency heart rate variability before, during and after the stimulation. The Fisher Wallace Stimulator (FW100) which delivers a low dose alternating current a varying frequencies will be used for the stimulation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAutonomic Nervous System Imbalance
CountriesUnited States
CollaboratorsFisher Wallace Laboratories

Timeline

Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJun 16, 2014
Enrollment StartJan 11, 2013
Primary CompletionMar 15, 2013
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 12.0 years ago

Interventions

Cranial Electrical Stimulation Fisher-Wallace Stimulator (Model FW100)device

low voltage alternating current transcranial electrical stimulation